Security key
230770109
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q1 2017 13F Holders as of 31 Mar 2017
- Security type / class
- Equity / Common stock
- Total 13F shares
- 5,505,762
- Total 13F value
- $38,201,000
- Share change
- +448,747
- SEC-reported price per share
- $6.94
- Number of holders
- 34
- Value change
- +$3,117,539
- Number of buys
- 14
- Number of sells
- 7
- Shares outstanding
- 15,075,924
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2017
Institutions
34
Top holders
10
CPIX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2017
Previous quarter: Q4 2016
CUMBERLAND PHARMACEUTICALS INC SEC filings
CUMBERLAND PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 230770109
Recent filing periods:
Ownership snapshot
Top reported holders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARIEL INVESTMENTS, LLC
Disclosed value leader
ARIEL INVESTMENTS, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
ARIEL INVESTMENTS, LLC leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARIEL INVESTMENTS, LLC's linked filing trail.
Comparable ownership
Top 5
ARIEL INVESTMENTS, LLC
12%
DIMENSIONAL FUND ADVISORS LP
5.7%
Stonepine Capital Management, LLC
4.1%
BlackRock Institutional Trust Com...
2.5%
VANGUARD GROUP INC
2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARIEL INVESTMENTS, LLC |
13F
Company
|
12%
|
$10,035,000
1,824,580 shares
|
— | 31 Dec 2016 |
| DIMENSIONAL FUND ADVISORS LP |
13F
Company
|
5.7%
|
$4,691,000
852,976 shares
|
— | 31 Dec 2016 |
| Stonepine Capital Management, LLC |
13F
Company
|
4.1%
|
$3,407,000
619,538 shares
|
— | 31 Dec 2016 |
| BlackRock Institutional Trust Company, N.A. |
13F
Company
|
2.5%
|
$2,099,000
381,679 shares
|
— | 31 Dec 2016 |
| VANGUARD GROUP INC |
13F
Company
|
2%
|
$1,636,000
297,455 shares
|
— | 31 Dec 2016 |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
Company
|
1.9%
|
$1,592,000
289,374 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
34
Shares
5,505,762
Rows available
34
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
37
Q1 2017 holders
34
Holder diff
-3
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend